Bayer Acquires AskBio to Expand Gene Therapy Platform
Bayer is making a big bet on gene therapy with the acquisition of North Carolina-based Asklepios BioPharmaceutical (AskBio).
This author has not written his bio yet.
But we are proud to say that Andrew Humphreys contributed 3897 entries already.
Bayer is making a big bet on gene therapy with the acquisition of North Carolina-based Asklepios BioPharmaceutical (AskBio).
The United States, Russia and France set new daily records for coronavirus infections as a second wave swelled across parts of the Northern Hemisphere, forcing some countries to impose new curbs.
South Korea’s Celltrion Inc. received emergency use authorization (EUA) from the U.S. Food and Drug Administration for the rapid Covid-19 testing kit Sampinute, which boosted shares of the company and its affiliates.
New York, the former epicenter of the U.S. Covid-19 pandemic, became the fourth U.S. state to surpass half a million coronavirus cases amid a nationwide surge in infections.
The United States saw the country’s highest-ever number of new Covid-19 cases in the past two days, keeping the pandemic a top election issue as Vice President Mike Pence travels the U.S. to campaign despite close aides testing positive.
U.S. infectious disease expert Anthony Fauci said it would be clear whether a Covid-19 vaccine was safe and effective by early December, but that more widespread vaccination would not be likely until later in 2021.
(Reuters) – Europe became the second region after Latin America to surpass 250,000 deaths on Saturday, according to a Reuters tally, with record numbers of daily COVID-19 infections reported in the past two weeks.
The United States broke the country’s daily record for new coronavirus infections with a reported 84,218 new cases due to outbreaks in virtually every part of the country, according to a Reuters tally.
The number of confirmed coronavirus infections in France jumped over 1 million, the health ministry reported.
Federal health regulators decided to allow the resumption of the U.S. trial of a leading Covid-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported, citing a person familiar with the matter and materials reviewed by it.